1. Home
  2. CDTG vs IRD Comparison

CDTG vs IRD Comparison

Compare CDTG & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTG
  • IRD
  • Stock Information
  • Founded
  • CDTG 2012
  • IRD 2018
  • Country
  • CDTG China
  • IRD United States
  • Employees
  • CDTG N/A
  • IRD N/A
  • Industry
  • CDTG
  • IRD
  • Sector
  • CDTG
  • IRD
  • Exchange
  • CDTG NYSE
  • IRD NYSE
  • Market Cap
  • CDTG 34.6M
  • IRD 36.0M
  • IPO Year
  • CDTG 2024
  • IRD N/A
  • Fundamental
  • Price
  • CDTG $1.41
  • IRD $1.13
  • Analyst Decision
  • CDTG
  • IRD Strong Buy
  • Analyst Count
  • CDTG 0
  • IRD 1
  • Target Price
  • CDTG N/A
  • IRD $8.00
  • AVG Volume (30 Days)
  • CDTG 73.2K
  • IRD 150.5K
  • Earning Date
  • CDTG 04-03-2025
  • IRD 02-24-2025
  • Dividend Yield
  • CDTG N/A
  • IRD N/A
  • EPS Growth
  • CDTG N/A
  • IRD N/A
  • EPS
  • CDTG 0.72
  • IRD N/A
  • Revenue
  • CDTG $31,432,824.00
  • IRD $8,381,000.00
  • Revenue This Year
  • CDTG N/A
  • IRD N/A
  • Revenue Next Year
  • CDTG N/A
  • IRD $29.37
  • P/E Ratio
  • CDTG $1.96
  • IRD N/A
  • Revenue Growth
  • CDTG N/A
  • IRD N/A
  • 52 Week Low
  • CDTG $1.16
  • IRD $0.81
  • 52 Week High
  • CDTG $4.64
  • IRD $2.71
  • Technical
  • Relative Strength Index (RSI)
  • CDTG N/A
  • IRD N/A
  • Support Level
  • CDTG N/A
  • IRD N/A
  • Resistance Level
  • CDTG N/A
  • IRD N/A
  • Average True Range (ATR)
  • CDTG 0.00
  • IRD 0.00
  • MACD
  • CDTG 0.00
  • IRD 0.00
  • Stochastic Oscillator
  • CDTG 0.00
  • IRD 0.00

About CDTG CDT ENVIRONMENTAL TECH INV HLDG LTD

CDT Environmental Technology Investment Holdings Ltd is a waste treatment company. The company generates revenue through the design, development, manufacture, sales, installation, operation and maintenance of sewage treatment systems and by providing sewage treatment services. It engages in two business lines namely, rural sewage treatment and septic tank treatment in both urban and rural areas.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: